In conclusion, this study found that COL8A1 derived from THBS2 + CAFs interacting with ITGB1 enhances EMT activity via the PI3K-AKT pathway leading to oxaliplatin resistance in CRC. The gene discussed is AKT1; the disease is colorectal carcinoma.